4UTG image
Entry Detail
PDB ID:
4UTG
Keywords:
Title:
Burkholderia pseudomallei heptokinase WcbL,AMPPNP (ATP analogue) complex.
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2014-07-21
Release Date:
2016-01-13
Method Details:
Experimental Method:
Resolution:
1.93 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:SUGAR KINASE
Mutations:YES
Chain IDs:A, B
Chain Length:346
Number of Molecules:2
Biological Source:BURKHOLDERIA PSEUDOMALLEI K96243
Primary Citation
Unraveling the B.Pseudomallei Heptokinase Wcbl: From Structure to Drug Discovery.
Chem.Biol. 22 1622 ? (2015)
PMID: 26687481 DOI: 10.1016/J.CHEMBIOL.2015.10.015

Abstact

Gram-negative bacteria utilize heptoses as part of their repertoire of extracellular polysaccharide virulence determinants. Disruption of heptose biosynthesis offers an attractive target for novel antimicrobials. A critical step in the synthesis of heptoses is their 1-O phosphorylation, mediated by kinases such as HldE or WcbL. Here, we present the structure of WcbL from Burkholderia pseudomallei. We report that WcbL operates through a sequential ordered Bi-Bi mechanism, loading the heptose first and then ATP. We show that dimeric WcbL binds ATP anti-cooperatively in the absence of heptose, and cooperatively in its presence. Modeling of WcbL suggests that heptose binding causes an elegant switch in the hydrogen-bonding network, facilitating the binding of a second ATP molecule. Finally, we screened a library of drug-like fragments, identifying hits that potently inhibit WcbL. Our results provide a novel mechanism for control of substrate binding and emphasize WcbL as an attractive anti-microbial target for Gram-negative bacteria.

Legend

Protein

Chemical

Disease

Primary Citation of related structures